Complementary strategies to elucidate T helper cell epitopes in myasthenia gravis

J Neuroimmunol. 2008 Sep 15:201-202:41-9. doi: 10.1016/j.jneuroim.2008.06.010. Epub 2008 Jul 22.

Abstract

CD4(+) T cells specific for the acetylcholine receptor (AChR) are assumed to play an important role in pathogenesis of myasthenia gravis (MG). A large and diverse number of potential T cell epitopes have been reported for different experimental setups aiming at the identification of disease-relevant T cells in MG. Investigating the T cell response to the epsilon subunit of human AChR, we explore complementary in vitro and in vivo approaches (PBMC from MG patients and mice transgenic for HLA-DR3 and human CD4) to address the possibilities and limitations of different strategies for elucidating natural autoimmune T cell epitopes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Apolipoprotein B-100 / pharmacology
  • CD4 Antigens / genetics
  • Dose-Response Relationship, Drug
  • Epitope Mapping*
  • Epitopes / physiology*
  • HLA-DR3 Antigen / genetics
  • Humans
  • Mice
  • Mice, Transgenic
  • Myasthenia Gravis / blood
  • Myasthenia Gravis / pathology*
  • Peptide Fragments / immunology
  • Protein Binding / drug effects
  • Receptors, Nicotinic / chemistry*
  • Receptors, Nicotinic / immunology
  • Receptors, Nicotinic / metabolism
  • T-Lymphocytes, Helper-Inducer / immunology*

Substances

  • Apolipoprotein B-100
  • CD4 Antigens
  • CHRNE protein, human
  • Epitopes
  • HLA-DR3 Antigen
  • Peptide Fragments
  • Receptors, Nicotinic